INDICATION OF GANCICLOVIR TREATMENT DURING EARLY CYTOMEGALOVIRUS (CMV) VIREMIA IN CMV SEROPOSITIVE RECIPIENTS - A LONGITUDINAL-STUDY OF CMVPP65 ANTIGENEMIA (AG) ASSAY
Cw. Yang et al., INDICATION OF GANCICLOVIR TREATMENT DURING EARLY CYTOMEGALOVIRUS (CMV) VIREMIA IN CMV SEROPOSITIVE RECIPIENTS - A LONGITUDINAL-STUDY OF CMVPP65 ANTIGENEMIA (AG) ASSAY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3404-3404